Sheena G. Sullivan, PhD

Monash University, Australia

Disclosure(s): Astra-Zeneca: Advisor/Consultant; CSL Behring and CSL Seqirus: Advisor/Consultant; GSK: Advisor/Consultant; Moderna: Advisor/Consultant; Novavax: Advisor/Consultant; Pfizer: Advisor/Consultant; Sanofi: Advisor/Consultant

Poster(s):

• (P-519) Detection & Severity of Respiratory Virus Co-Infections with SARS-CoV-2, Influenza, or RSV in U.S. Children <2 Years Old
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1473) Estimated Relative Effectiveness and Public Health Impact of Cell-Based Versus Egg-Based Influenza Vaccines During the 2023–2024 Season in the United States
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1594) Incidence and Severity of Post-Pandemic SARS-CoV-2 Infection during Pregnancy
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET